Ionis headquarters
Pharma

FDA approves transformational expansion of Ionis’ Tryngolza

Ionis has gained a transformational FDA expansion for Tryngolza to become the first treatment to reduce the risk of acute pancreatitis that accompanies severe hypertriglyceridemia.
Kevin Dunleavy Jun 25, 2026 8:13am
Beyond China and Japan How biopharma is expanding rare disease access across Asia-Pacific

Beyond China and Japan: How biopharma is expanding rare disease access across Asia-Pacific

Brought to you by DKSH
FDA

FDA issues Form 483 to Dr. Reddy's plant in India

Jun 26, 2026 11:40am
The legacy approach to real-world data is costing you

The legacy approach to real-world data is costing you

Brought to you by HealthVerity
Sanofi

EC begins antitrust probe into Sanofi's flu shot campaign

Jun 26, 2026 11:20am
European Union flag

Europe's CHMP reverses endorsement of Amgen's Tavneos

Jun 26, 2026 11:07am
More News

Regulatory tracker: Keytruda-Padcev wins EU expansion

Jun 26, 2026 10:38am

Solid tumor CAR-T, Pfizer-Innovent, China deals—Fierce Pharma Asia

Jun 26, 2026 8:51am

BeOne boosts support for Blood Cancer United with $5M commitment

Jun 26, 2026 3:57am

Fosun Pharma plots global push, fueled by Alzheimer’s deals

Jun 25, 2026 7:00pm